What Makes a Psychedelic Therapist Effective?
As psychedelic-assisted therapy (PAT) moves toward regulatory approval, understanding what makes therapists effective becomes increasingly important. This article examines what the current evidence reveals about good psychedelic therapy practice, how these competencies are being operationalized in training, and what standardization the field still needs.
What Predicts Good Outcomes?
Good outcomes depend less on the drug itself than on what therapists do: how they structure preparation, design the setting, and frame expectations. A systematic review examining 54 clinical trials found that the intensity of the acute psychedelic experience predicts better therapeutic response most consistently, especially mystical type experiences (MTEs), understood as profound spiritual or transcendent moments during the session (Viljoen et al., 2025). However, this relationship was not consistent across all disorders or measurement points. This inconsistency reveals that the quality of the experience alone does not guarantee the quality of the outcome.
What matters more is set, setting, and dose. Importantly, rather than being passive features of the treatment context, they are actively constructed by therapists through preparation work, environmental design, therapeutic presence, and how expectations are framed. It is about what the therapist does to create the conditions for therapeutic change.
The Therapeutic Alliance
The relationship between therapist and client matters as much as the psychedelic itself. It is the foundation that determines whether the experience becomes healing or harmful. Therapeutic Alliance refers to the cooperative connection between client and therapist built on respect for client autonomy, listening skills, and practical concern for the patient’s wellbeing. Decades of research show it predicts outcomes across all therapeutic approaches.
However, in PAT, the alliance remains underexplored and under-measured. Recent methodological critiques have questioned whether prior estimates of the alliance’s impact were inflated due to statistical limitations. But rather than diminishing its importance, this controversy underscores why the alliance deserves closer examination in the PAT context. Including alliance measures in clinical trials would not require extensive resources, and the insights could substantially advance understanding of PAT mechanisms (Kamilar-Britt et al., 2023).
What do experienced therapists themselves identify as predicting positive outcomes? A survey of 158 therapists working in the field identified therapeutic alliance as the strongest predictor of favourable long-term outcomes, alongside robust social support, personality traits such as openness (comfort with novelty and new experiences) and capacity to surrender, secure attachment, and belief in an active mode of therapeutic action. Across open-ended responses, preparation, integration, patient mindset, and environmental context emerged as critical themes (Viljoen et al., 2026).
One emerging dimension of alliance work in PAT is co-therapy, in which two therapists jointly support the patient throughout preparation, dosing and integration sessions. Co-therapy enhances safety and trust while potentiating therapeutic processes, though it requires careful management of the multiple therapeutic relationships that develop in the treatment room (Ham et al., 2026).
Competencies Beyond Credentials
Effective psychedelic therapists need five competencies that go beyond credentials: therapeutic presence, cultural literacy, regulatory knowledge, clinical understanding, and trauma-informed skills. A Canadian university programme identified these competencies through research, refined over four years through feedback from learners, faculty, clinical supervisors, and cultural knowledge keepers (Dames et al., 2026). They are:
| Competency Domain | What It Involves |
|---|---|
| Therapeutic Presence | Attentive, grounded engagement and relational authenticity |
| Culture and Identity | Understanding how cultural background and social location shape experience |
| Regulatory Literacy | Knowledge of legal, ethical, and professional frameworks governing practice |
| Clinical Knowledge | Evidence-based understanding of PAT mechanisms, pharmacology, and treatment protocols |
| Trauma-Informed Process | Awareness of how trauma affects people and adapting screening, preparation, informed consent, and integration with attention to trauma history and equity |
These domains span both “doing” (technical and clinical skills) and “being” (relational presence and ethical stance). They reflect a recognition that PAT requires more than pharmacological knowledge or protocol adherence.
What do these competencies look like in practice? A historical review examining pre-prohibition and contemporary psychedelic research provides perspective (Kishon et al., 2024). The research consistently highlights the role of clinician presence, non-pharmacological treatment factors, and psychological interventions in determining patient outcomes. In other words, what therapists do during preparation, during the session, and during integration matters as much as the pharmacological intervention itself. These findings inform current understanding of what training programmes should emphasize and what best practice guidelines should include.
Set and Setting: The Two Dimensions Therapists Must Master
Therapists actively shape the psychedelic experience by structuring the patient’s mindset (set) and designing the physical and relational environment (setting).
Set refers to the patient’s expectations, anxieties, hopes, and mental preparation. Preparation sessions directly address set through psychoeducation, establishing safety, discussing potential experiences, and helping patients develop an appropriate mindset for the session. The quality of this preparation work shapes what patients bring into the dosing session.
Setting refers to the therapeutic space itself, the presence and demeanour of the therapist, the sensory environment, the social context, and the therapeutic frame. These are not passive background features. Therapists deliberately design and maintain the setting through attention to environmental elements, consistency and therapeutic presence, and careful management of the therapeutic relationship (Hartogsohn, 2024).
The significance of set and setting extends across all contexts of psychedelic use. Whether in clinical trials, therapeutic practice, or harm reduction settings, understanding how to shape these dimensions represents core clinical knowledge. This is why training in PAT necessarily involves instruction not only in what to do clinically, but in how to create and maintain the conditions under which therapeutic work becomes possible.
Current Debate: Do Psychedelic Therapists Need Personal Experience?
Research does not support requiring personal psychedelic experience for competent practice, though it can be valuable if therapists choose it. A persistent question in the field is whether therapists working with psychedelics should have personal experience with those substances themselves. The reasoning seems intuitive: how can therapists guide patients through an experience they have never had? Can they truly understand the phenomenology of a mystical experience, ego dissolution (the temporary dissolution of the sense of individual self), or psychological breakthrough without having lived through it?
The evidence contradicts this assumption. A comprehensive analysis examining this question found that whilst personal psychedelic experience can be valuable to both therapists and patients, current research does not justify requiring it as a prerequisite for training (Villiger, 2024). It examined evidence from parallel situations in therapy and found inconsistent support for a requirement model.
This does not mean personal experience is without value. Therapists who have had a psychedelic experience may develop embodied understanding of the states they are facilitating. They may have greater intuitive grasp of what patients are describing. However, such understanding can also be developed through extensive clinical work, supervision, and engagement with patient narratives. Moreover, personal experience carries its own risks, including the possibility that a therapist’s own experience becomes a template through which they interpret all patient experiences.
The nuanced position emerging from the evidence is thus: therapists should be given the opportunity to have a psychedelic experience during their training if they choose to, but it should not be a requirement for competent practice. This reflects a mature approach to training that acknowledges both the potential value and the potential limitations of personal experience.
Harm Reduction
Challenging experiences during psychedelic sessions are common and can become therapeutic. Harm reduction training helps therapists support clients through them. How therapists respond to these moments determines whether they become harmful or transformative.
Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical clinical model to address this challenge (Hu et al., 2024). The model integrates principles from harm reduction psychotherapy, PAT, mindfulness-based approaches, and psychodynamic therapy. Rather than viewing integration solely as a post-experience phase, PHRI positions it as central to the entire treatment arc, beginning in preparation and continuing throughout and after the dosing sessions.
What does this mean practically? Therapists trained in harm reduction approaches learn to address common challenging experiences such as fear, ego dissolution, emotional overwhelm, and enhanced sensitivity. They develop skills to support clients in metabolizing difficult material within the session and in ongoing integration work. They understand that psychological flexibility, somatic awareness, and non-pathologizing approaches to difficult experiences can transform potentially harmful moments into opportunities for deeper therapeutic work.
Therefore, harm reduction represents not a specialized add-on to PAT training, but a core competency that all practitioners working with psychedelics should possess. Understanding how to minimize potential harms and support clients through challenging experiences is inseparable from understanding how to maximize therapeutic benefit.
The Training Gap: What’s Still Needed?
Training programmes exist but vary widely in quality. The field needs standardized competencies, shared certification standards, and consistent curricula. Psychotherapists emphasise the need for formal training standards, research-informed curricula, professional oversight, and ethical governance (Kinahan & Wilson, 2025).
Demand for training far exceeds supply. Some programmes are responding to this need. Switzerland’s Swiss Medical Association for Psychedelic Therapy (SAPT) offers a comprehensive three-year training programme for physicians and psychologists, integrating theoretical knowledge with hands-on supervised practice (Aicher et al., 2025). The curriculum emphasises the therapeutic relationship, ethical considerations, and the management of altered states of consciousness. Yet demand for these programmes far exceeds current supply, and this gap will widen as psychedelics move toward regulatory approval.
Several organisations have begun expanding their educational offerings to meet demand, including further education trainings, workshops, conferences, and symposia. However, inconsistency in programme quality, depth, and rigour remains a concern. The field has not yet established shared certification standards or agreed upon core competencies that all training programmes should meet. As the field matures, developing consistent, accessible, and rigorous training models will be essential to ensure the safe and effective use of PAT across diverse clinical settings.
How Training Bridges Theory and Practice
Effective training embeds competency development in real clinical work, not in classrooms alone.
The Canadian competency framework discussed earlier exemplifies this approach (Dames et al., 2026). Rather than establishing a fixed, externally validated standard, the framework was developed through an iterative quality improvement process that integrated evidence-based literature with ongoing feedback from learners, supervisors, and clinical partners. This approach recognizes that training must be adaptive. PAT is a rapidly evolving field, and training programmes must be flexible enough to incorporate new evidence and respond to diverse clinical contexts.
Different programmes operationalise these competencies in different ways. Switzerland’s SAPT emphasises a three-year model combining didactic teaching with practical retreats and supervised clinical work. Other emerging programmes are developing shorter intensive trainings, online learning components, and distributed models that make training more accessible whilst maintaining rigour. The diversity of approaches reflects recognition that there may not be a single “correct” way to train psychedelic therapists, but rather multiple pathways that can achieve the same core competencies.
What matters is that training programmes are explicit about the competencies they are building, that they ground learning in actual clinical practice, and that they create mechanisms for ongoing quality improvement and adaptation.
OPEN’s Approach to Psychedelic Therapist Training
OPEN offers a flexible two-tier pathway: Foundations provides theoretical grounding for newcomers, while ADEPT builds full clinical competency through hybrid learning and supervised practice. The OPEN Foundation has created a tiered approach to psychedelic therapist education that reflects the principles discussed throughout this article (OPEN Foundation, 2026a; 2026b).
| Programme | Foundations of Psychedelic Therapy | ADEPT |
|---|---|---|
| Target Audience | Mental health practitioners new to the field | Practitioners seeking comprehensive clinical qualification |
| Duration | 13 months | 2 years |
| Format | Online (pre-recorded lectures, live tutor groups, Q&A sessions) | Hybrid (theory combined with mandatory practical and hands-on learning) |
| Focus | Theoretical grounding in clinical, ethical, cultural, and scientific dimensions of PAT | Full competency development including mentorship, supervised clinical practice, and interactive training |
Completion of Foundations counts toward the requirements of the full ADEPT programme, creating a flexible pathway for practitioners to begin their engagement at the foundational level and progress to comprehensive clinical qualification as their commitment and expertise develop.
Beyond initial training, OPEN maintains an active community of practitioners through ongoing professional development opportunities including journal clubs, masterclasses, and access to scientific conferences. This ensures that training does not end with programme completion but rather becomes part of an ongoing commitment to evidence-informed practice and professional development.
Collectively, these offerings represent an attempt to operationalize the core insight that emerges from current research: good psychedelic therapy practice is not something that can be transmitted through credentials alone. It requires sustained engagement with both theory and practice, ongoing supervision, peer learning, and commitment to the specific competencies that the field is beginning to articulate.
References
Aicher, H. D., Müller, F., & Gasser, P. (2025). Further education in psychedelic-assisted therapy—experiences from Switzerland. BMC Medical Education, 25, 341. https://doi.org/10.1186/s12909-025-06871-y
Dames, S., Williams, K., Campbell, A., Taylor, W., Harder, M., Gagnon, M., Manson, G., & Kryskow, P. (2026). Competencies and ethical governance for psychedelic-assisted therapies: A practice-embedded quality-improvement framework. Journal of Evaluation in Clinical Practice, 32(5), e70556. https://doi.org/10.1111/jep.70556
Ham, R., Gardner, J., Carter, A., & Liknaitzky, P. (2026). ‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy. Psychology and Psychotherapy: Theory, Research and Practice, Early View. https://doi.org/10.1111/papt.70098
Hartogsohn, I. (2024). Set and setting for psychedelic harm reduction. In Psychedelic Harm Reduction (pp. 299–312). Springer. https://doi.org/10.1007/7854_2024_509
Hu, X., Gorman, I., & Nielson, E. (2024). Psychedelic harm reduction and integration: A transtheoretical model for clinical practice. In Psychedelic Harm Reduction (pp. 397–416). Springer. https://doi.org/10.1007/7854_2024_529
Kamilar-Britt, P., Gordis, E. B., & Earleywine, M. (2023). The therapeutic alliance in psychedelic-assisted psychotherapy: A novel target for research and interventions. Psychedelic Medicine, 1(4), 262–266. https://doi.org/10.1089/psymed.2023.0020
Kinahan, S., & Wilson, E. (2025). Perspectives of psychotherapists regarding psychedelic assisted therapy. Counselling and Psychotherapy Research, 25(1), e12881. https://doi.org/10.1002/capr.12881
Kishon, R., Modlin, N. L., Cycowicz, Y. M., Mourtada, H., Wilson, T., Williamson, V., Cleare, A., & Rucker, J. (2024). A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials. npj Mental Health Research, 3, 33. https://doi.org/10.1038/s44184-024-00068-9
OPEN Foundation. (2026a). Foundations of psychedelic therapy: Curriculum. Retrieved from https://open-foundation.org/foundations-of-psychedelic-therapy/curriculum/
OPEN Foundation. (2026b). ADEPT psychedelic therapy training: ADEPT curriculum. Retrieved from https://open-foundation.org/adept-psychedelic-therapy-training/adept-curriculum/
Viljoen, G., Bendau, A., Walter, H., Mertens, L. J., Evens, R., Wolff, M., Herwig, U., Johnson, M., Seynaeve, M., Koslowski, M., & Betzler, F. (2026). Therapist-rated predictors of response to psychedelic-assisted therapy. Nature Mental Health, 4, 951–961. https://doi.org/10.1038/s44220-026-00642-4
Viljoen, G., Walter, H., Bendau, A., Koslowski, M., & Betzler, F. (2025). Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review. Journal of Psychopharmacology, 40(5), 703–719. https://doi.org/10.1177/02698811251389581
Villiger, D. (2024). Personal psychedelic experience of psychedelic therapists during training: Should it be required, optional, or prohibited? International Review of Psychiatry, 36(8), 869–878. https://doi.org/10.1080/09540261.2024.2357669
AUTHOR
Dilara Meral Oexemann
Dilara is an early-career researcher and science communicator based in Berlin with a master’s degree in clinical psychology from Erasmus University Rotterdam. Her thesis examined the effects of dose, personality, and emotional breakthrough on the persisting outcomes of psychedelics, and she is currently preparing this work for journal publication.
She contributes to Blossom, where she helps maintain their research database and review clinical trials. Additionally, she is trying to get involved in the psychedelic research landscape in Europe.
Her interests centre on individual differences in psychedelic response, mechanisms of psychedelic use, and how personality and relational factors influence psychedelic outcomes.
